Regulation & legislation

Getty | artjazz

EU sector challenges: Science on our side so where's the policy?

By Nikki Hancocks

Thriving international markets, strict EU regulation and tight transition periods are big challenges for those in the EU supplements market but Food Supplements Europe (FSE) is uniting the industry in a fight for positive legislative changes.

IPAWC + Probiota 2023: Early bird discount expires this week

IPAWC + Probiota 2023: Early bird discount expires this week

By Stephen Daniells

From the phage opportunity to microbiome modulation for athletic performance, the science around HMOs, synbiotic mechanisms of action, and the gut-brain axis, the upcoming IPA World Congress + Probiota is not to be missed.

© Getty Images / Nastco

ADM identifies key microbiome trends

By Kavitha Sivasubramaniam

Global nutrition company ADM has announced its top predictions for the fast-growing global microbiome market based on findings from its consumer insights platform, Outside Voice.

© Getty Images

Editor's Spotlight

Vitamin enhanced juice firm clearing hurdles

By Liza Laws

An Australian living in London has overcome an extraordinary set of challenges including Brexit, the pandemic and more recently a sharp rise in prices as a result of the war in Ukraine to keep his vitamin enhanced juice business thriving.

A science lab with measuring cylinders. ©Getty Images

Science shorts: NAD+, NMN, vitamin E in the spotlight

By Tingmin Koe

This round-up of new scientific findings will look at how low NAD+ level is associated with anaemia in women, Mitsubishi Life Sciences’ NMN clinical study findings, and the benefits of vitamin E for exercise recovery and PCOS.

Polyana and Marcela Tupinamba

Mother and daughter's dream teas pandemic success

By Liza Laws

This is a lockdown success story about a mother and daughter from Brazil who moved to Sussex and wanted to create functional teas that not only did what they said on the tin but tasted good too.

©Getty Images - David Trood

FDA slams Delta-8 THC sellers over claims

By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

Follow us

Products

View more

Webinars